Oncology and biomedicine terminology · MLC-0111

Oncology and biomedicine terms: A (3,095)

Page 6 of 7

• Autoimmune diseaseA condition in which the body’s immune system mistakes its own healthy tissues as foreign and attacks them...
• Autoimmune enteropathyA rare disease in which certain cells in the intestine are destroyed by a patient’s immune system. It causes...
• Autoimmune hemolytic anemiaA condition in which the body’s immune system stops red blood cells from forming or causes them to clump...
• Autoimmune paraneoplastic diseaseA condition that can occur in some people with cancer when the body’s immune system becomes overactive and...
• Autoimmune thyroiditisAn autoimmune condition of the thyroid gland (a gland located beneath the larynx). It is caused by the...
• AutologousTaken from an individual's own tissues, cells, or DNA.
• Autologous 1928T2z CAR T cells WZTL-002A preparation of autologous, third-generation T lymphocytes that have been transduced with a...
• Autologous 19-28z/IL-18 CAR T lymphocytesA preparation of autologous T lymphocytes engineered to express a chimeric antigen receptor (CAR) specific...
• Autologous 4-1BB selected tumor infiltrating lymphocytesA preparation of autologous tumor infiltrating lymphocytes (TILs) expressing the co-stimulatory signaling...
• Autologous ACTR-CD16-CD28-expressing T lymphocytes ACTR707A preparation of autologous T lymphocytes that have been genetically modified, using proprietary...
• Autologous Ad-CD154-transduced CLL B cellsAn autologous tumor cell vaccine containing chronic lymphocytic leukemia (CLL) B cells transduced with an...
• Autologous AFP-specific T cell receptor T cells C-TCR055A preparation of human autologous T lymphocytes transduced with a lentiviral vector encoding for a T-cell...
• Autologous ALPG/ALPP-targeted anti-MSLN CAR-Fas/PTPN2 shRNA-miR-expressing T lymphocytes AB-1015A preparation of autologous T lymphocytes that have been modified to encode a genetic circuit consisting of a...
• Autologous alpha-PNE switchable CAR T cells CLBR001A preparation of autologous T lymphocytes that has been genetically engineered to express a switchable...
• Autologous alpha-PNE switchable CAR T cells CLBR001 and CD19-specific adapter molecule SWI019A combination of CLBR001, a preparation of autologous T lymphocytes that has been genetically engineered to...
• Autologous AML/dendritic cell fusion vaccineA therapeutic cell-based cancer vaccine consisting of autologous dendritic cells (DCs) fused with autologous...
• Autologous anti-ALK CAR T cellsA preparation of autologous T lymphocytes that have been genetically engineered to express a chimeric antigen...
• Autologous anti-ALPP CAR retroviral vector-transduced T cellsA preparation of autologous T lymphocytes that have been transduced with a retroviral vector expressing a...
• Autologous anti-B7-H3 CAR retroviral vector-transduced T cellsA preparation of autologous T lymphocytes that have been transduced with a retroviral vector expressing a...
• Autologous anti-B7-H3 CAR T cellsA preparation of autologous T lymphocytes that have been genetically engineered to express a chimeric antigen...
• Autologous anti-B7-H3 CAR T cells CAR.B7-H3TA preparation of autologous T lymphocytes that have been genetically engineered to express a chimeric antigen...
• Autologous anti-B7-H3 CAR-iC9-expressing T lymphocytesA preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous anti-B7-H3/CD19 CAR T cells SCRI-CARB7H3(s)x19A preparation of autologous CD4+ and CD8+ T lymphocytes lentivirally transduced to express a chimeric antigen...
• Autologous anti-BCMA CAR T cells MCARH125A preparation of autologous T lymphocytes that have been genetically engineered to express a chimeric antigen...
• Autologous anti-BCMA CAR T cells PHE885A preparation of autologous T lymphocytes that have been genetically engineered to express a chimeric antigen...
• Autologous anti-BCMA CAR T cells spCART-269A preparation of autologous T lymphocytes that have been genetically engineered to express a chimeric antigen...
• Autologous anti-BCMA CAR T cells UF-KURE-BCMAA preparation of autologous CD4+ and CD8+ T lymphocytes that have been transduced with a lentiviral vector...
• Autologous Anti-BCMA CAR T-cells IM21A preparation of autologous T-lymphocytes that have been transduced with a lentiviral vector (LV) expressing...
• Autologous anti-BCMA CAR-transduced T cells KITE-585A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous anti-BCMA CD8+ CAR T cells Descartes-11A preparation of autologous CD8-positive T lymphocytes that have been genetically modified to express a...
• Autologous anti-BCMA-CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ T lymphocytesA preparation of an approximately equal ratio of autologous CD4- and CD8-positive T lymphocytes that have...
• Autologous anti-BCMA-CAR-4-1BB-CD3zeta-expressing CD4+/CD8+ T lymphocytes JCARH125A preparation of autologous CD4- and CD8-positive T lymphocytes that have been ex vivo transduced with a...
• Autologous anti-BCMA-CAR-4-1BB-CD3zeta-expressing memory T lymphocytes bb21217A preparation of autologous memory T lymphocytes transduced, ex vivo, with a lentiviral vector expressing a...
• Autologous anti-BCMA-CAR-4-1BB-CD3zeta-expressing T cells C-CAR088A preparation of autologous T lymphocytes that have been transduced with a vector expressing a chimeric...
• Autologous anti-BCMA-CAR-4-1BB-CD3zeta-expressing T cells CT053A preparation of autologous T lymphocytes that have been transduced with a vector expressing a chimeric...
• Autologous anti-BCMA-CAR-4-1BB-expressing T cells NXC-201A preparation of autologous T lymphocytes that have been transduced with a retroviral vector encoding for a...
• Autologous anti-BCMA-CAR-expressing CD4+/CD8+ T lymphocytes FCARH143A preparation of ex vivo expanded autologous CD8+ and CD4+ T cells that have been genetically modified to...
• Autologous anti-BCMA-CAR-expressing stem memory T cells P-BCMA-101A preparation consisting of autologous T cells that are enriched to be primarily stem memory T cells (Tscm)...
• Autologous anti-BCMA-CAR-mRNA-transfected CD8+ T lymphocytesA preparation of autologous CD8-positive T lymphocytes that have been genetically modified via transient mRNA...
• Autologous anti-BCMA-CAR-TCRz/4-1BB-expressing T lymphocytes CART-BCMAA preparation of autologous T lymphocytes that have been ex vivo transduced with a genetically-engineered...
• Autologous anti-BCMA/CS1 bispecific CAR-T cellsA preparation of autologous T lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting...
• Autologous anti-CD123 CAR TCR/4-1BB-expressing T lymphocytesAutologous, genetically engineered T lymphocytes that have been electroporated with a messenger RNA (mRNA)...
• Autologous anti-CD123 CAR-T cellsA preparation of autologous T cells engineered to express a chimeric antigen receptor (CAR) specific for the...
• Autologous anti-CD147 CAR T cellsA preparation of autologous activated T cells that have been engineered to express chimeric antigen receptors...
• Autologous anti-CD19 AbTCR-expressing T lymphocytes EB103A preparation of autologous T lymphocytes transduced with a lentiviral vector encoding an...
• Autologous anti-CD19 CAR T cells 19(T2)28z1xxA preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous anti-CD19 CAR T cells GC019FA preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous anti-CD19 CAR T cells GLPG5101A preparation of autologous stem-like early memory T lymphocytes that have been genetically engineered to...
• Autologous anti-CD19 CAR TCR-zeta/4-1BB-transduced T lymphocytes BinD19Autologous T lymphocytes that have been transduced with a lentiviral vector to express a T-cell receptor...
• Autologous anti-CD19 CAR TCR-zeta/4-1BB-transduced T lymphocytes huCART19Autologous T lymphocytes that have been transduced with a lentiviral vector to express a chimeric antigen...
• Autologous anti-CD19 CAR vector-transduced T cells pCAR-19BA preparation of autologous T lymphocytes that have been genetically modified and transduced with a vector...
• Autologous anti-CD19 CAR-4-1BB-CD3zeta-expressing T cells CNCT19A preparation of autologous T lymphocytes that are engineered to express a chimeric antigen receptor (CAR)...
• Autologous anti-CD19 CAR-CD28 T cells ET019002A preparation of autologous T lymphocytes that have been transduced with a lentiviral vector to express a...
• Autologous anti-CD19 CAR-CD3zeta-4-1BB-expressing T cellsA preparation of autologous T lymphocytes that are engineered to express a chimeric antigen receptor (CAR)...
• Autologous anti-CD19 CAR-CD3zeta-4-1BB-expressing T cells PZ01A preparation of autologous T lymphocytes that have been transduced with a lentiviral vector to express a...
• Autologous anti-CD19 CAR-CD8alpha-CD28-CD3zeta T cells KYV 101A preparation of autologous CD4- and CD8-positive T cells that are transduced with a lentiviral vector...
• Autologous anti-CD19 CAR-expressing T lymphocytesA preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous anti-CD19 CAR-expressing T lymphocytes CLIC-1901A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous anti-CD19 CAR-expressing T lymphocytes IC19/1563A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous anti-CD19 CAR-expressing T lymphocytes UF-KURE19A preparation of autologous T lymphocytes that have been genetically modified and transduced with a...
• Autologous anti-CD19 CAR-IL-18-expressing T lymphocytesA preparation of autologous T lymphocytes engineered to express a chimeric antigen receptor (CAR) specific...
• Autologous anti-CD19 CAR-T cells CABA-201A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous anti-CD19 CAR-T cells IM19A preparation of autologous T lymphocytes that have been genetically modified and transduced with a...
• Autologous anti-CD19 CAR-T cells TBI-1501Autologous T lymphocytes that have been transduced, via a proprietary technology involving a recombinant...
• Autologous anti-CD19 chimeric antigen receptor T cells C-CAR011A proprietary preparation of autologous T lymphocytes that have been genetically modified and transduced with...
• Autologous anti-CD19 chimeric antigen receptor T cells SJCAR19A proprietary preparation of autologous T lymphocytes that have been genetically modified to express a...
• Autologous anti-CD19 DASH CAR T cellsA preparation of autologous T lymphocytes that have been genetically modified and transduced with a...
• Autologous anti-CD19 TAC-T cells TAC01-CD19A preparation of autologous T lymphocytes genetically engineered with a T cell Antigen Coupler (TAC)...
• Autologous anti-CD19 T-cell receptor fusion construct T cells TC-110A preparation of autologous T lymphocytes that have been genetically engineered to express a single-domain...
• Autologous anti-CD19 T-cell receptor T cells ET190L1Autologous human peripheral blood T ymphocytes transduced with a lentivirus encoding a proprietary expression...
• Autologous anti-CD19/anti-CD20-CAR-CD28-4-1BB-CD3zeta-EGFRt+-expressing Tn/mem cellsA preparation of genetically modified autologous naive/memory T cells (Tn/mem), that have been transduced...
• Autologous anti-CD19/anti-CD79b CAR-expressing bispecific T cellsA preparation of autologous T lymphocytes that are genetically engineered to express a chimeric antigen...
• Autologous anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ central memory T lymphocytes JCAR014A defined preparation of CD4+ and CD8+ central memory (CM) autologous T lymphocytes transduced with a...
• Autologous anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing T lymphocytesA preparation of genetically modified CD8+ central memory (Tcm) and CD4+ autologous T-lymphocytes (1:1)...
• Autologous anti-CD19CAR-4-1BB/CD3zeta-HER2tG-expressing CD4+/CD8+ T lymphocytes SCRI-huCAR19v2A preparation of autologous CD4- and CD8-positive Tlymphocytes that have been transduced with a lentiviral...
• Autologous anti-CD19CAR-CD28tm/4-1BB/CD3zeta-HER2tG-expressing CD4+/CD8+ T lymphocytes SCRI-huCAR19v1A preparation of autologous CD4- and CD8-positive T lymphocytes that have been transduced with a...
• Autologous anti-CD19CAR-CD3zeta-4-1BB-IL-15-PD1-expressing tri-functional T lymphocytesA preparation of autologous T lymphocytes engineered to express a tri-functional chimeric antigen receptor...
• Autologous anti-CD19CAR-HER2t/CD22CAR-EGFRt-expressing T cellsA preparation of autologous human T lymphocytes engineered to express dual chimeric antigen receptors (CARs)...
• Autologous Anti-CD19/CD20 Bispecific Nanobody-based CAR-T cellsA preparation of autologous T-lymphocytes engineered to express a chimeric antigen receptor (CAR) that is...
• Autologous anti-CD19/CD20 CAR T cells KITE-363A preparation of autologous T lymphocytes engineered to express a chimeric antigen receptor (CAR) specific...
• Autologous anti-CD19/CD20/CD22 CAR T cellsA preparation of autologous T lymphocytes engineered to express a chimeric antigen receptor (CAR) specific...
• Autologous anti-CD19/CD22 CAR-T cells AUTO3A preparation of autologous T lymphocytes that have been transduced with a bicistronic retroviral vector...
• Autologous anti-CD1a CAR T cellsA preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous anti-CD1a CAR T cells OC-1A preparation of autologous T lymphocytes that have been transduced with a lentiviral vector expressing a...
• Autologous anti-CD20 CAR transduced CD4/CD8 enriched T cells MB-CART20.1A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous anti-CD20 CAR-CD28-4-1BB-CD3zeta T lymphocytes MB-106A preparation of autologous T lymphocytes that have been transduced with a lentiviral vector expressing a...
• Autologous anti-CD22 CAR-4-1BB-TCRz-transduced T lymphocytes CART22-65sAutologous human T lymphocytes transduced with a recombinant lentiviral vector encoding a chimeric antigen...
• Autologous anti-CD22 CAR-expressing T cells SCRI-CAR22v2A preparation of autologous human T lymphocytes that are genetically engineered to express a chimeric antigen...
• Autologous anti-CD22 CAR-T cells CLIC-2201A preparation of autologous T lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting...
• Autologous anti-CD30 CAR T cells HSP-CAR30A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous anti-CD38 A2 CAR2-expressing T cellsA preparation of genetically modified autologous T cells expressing a chimeric antigen receptor recognizing...
• Autologous anti-CD3/anti-EGFR bispecific antibody armed peripheral blood mononuclear cellsA preparation of autologous peripheral blood mononuclear cells (PBMCs) in which T lymphocytes are coated with...
• Autologous anti-CD3/anti-SLAMF7 bispecific antibody-armed activated T lymphocytesA preparation of autologous activated T lymphocytes that have been coated with a bispecific antibody...
• Autologous anti-CD4 CAR T cells LB1901A preparation of autologous T lymphocytes that have been genetically modified and transduced with a...
• Autologous anti-CD5 CAR monocytes MT-101A preparation of autologous monocytes genetically modified with mRNA technology to express a chimeric antigen...
• Autologous anti-CD5 CAR T lymphocytes MB-105A preparation of genetically modified autologous T cells expressing a chimeric antigen receptor (CAR)...
• Autologous anti-CD7 CAR T cells PA3-17A preparation of autologous T lymphocytes that have been genetically engineered to express a chimeric antigen...
• Autologous anti-CD7 CAR T cells SENL101A preparation of autologous T lymphocytes that have been genetically engineered to express a chimeric antigen...
• Autologous anti-CD7 CAR/28zeta CRISPR-edited T lymphocytesA preparation of autologous T lymphocytes (ATL) that have been gene-edited with the clustered regularly...
• Autologous anti-CD79a/anti-CD20 CAR T cells bbT369A preparation of genetically modified autologous T lymphocytes that are transduced with a single lentiviral...
• Autologous anti-CD79b CAR T cells JV-213A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous anti-CD7-CAR-CD28zeta T cellsA preparation of autologous T lymphocytes that have been genetically engineered to express a chimeric antigen...
• Autologous anti-CD83 CAR T cellsA preparation of autologous T lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting...
• Autologous anti-CDH17 CAR-T cells CHM-2101A preparation of autologous T lymphocytes transduced with a lentiviral vector expressing a chimeric antigen...
• Autologous anti-CEA CAR/HLA-A*02-gated inhibitory receptor/B2M shRNA-expressing T lymphocytes A2B530A preparation of autologous T lymphocytes from a human leukocyte antigen (HLA)-A*02-positive donor that have...
• Autologous anti-Claudin18.2 CAR T cells LB1908A preparation of autologous T lymphocytes engineered to express a chimeric antigen receptor (CAR) specific...
• Autologous anti-Claudin18.2-transduced T lymphocytes CT041A preparation of autologous T lymphocytes ex vivo transduced with a lentiviral vector encoding for a chimeric...
• Autologous anti-CLDN18.2 TAC T cells TAC01-CLDN18.2A preparation of autologous T lymphocytes that have been genetically engineered to express a T-cell Antigen...
• Autologous anti-CLDN6 CAR-NK cellsA preparation of autologous natural killer (NK) cells engineered to express a chimeric antigen receptor (CAR)...
• Autologous anti-CLL-1-CAR T lymphocytes BG1805A preparation of autologous T lymphocytes expressing a chimeric antigen receptor (CAR) specific for the...
• Autologous anti-CLL-1-CAR T lymphocytes KITE-222A preparation of autologous T lymphocytes expressing a chimeric antigen receptor (CAR) specific for the...
• Autologous anti-CS1 hinge-optimized CAR-4-1BB-EGFRt-expressing memory-enriched T cellsA preparation of autologous central memory-enriched T cells (Tcm) that have been transduced with a...
• Autologous anti-CSPG4 CAR-iC9-expressing T lymphocytesA preparation of T lymphocytes that have been genetically modified to express a chimeric antigen receptor...
• Autologous anti-DLL-3 CAR-T cells LB2102A preparation of autologous T lymphocytes that have been genetically engineered to express a chimeric antigen...
• Autologous anti-EBV CAR T cells BRG01A preparation of autologous T lymphocytes that are genetically engineered to express a chimeric antigen...
• Autologous anti-EGFR CAR-transduced CXCR 5-modified T lymphocytesA preparation of autologous, C-X-C chemokine receptor type 5 (CXCR 5)-modified T lymphocytes that have been...
• Autologous anti-EGFR/anti-IL13Ralpha2 CAR T cellsA preparation of autologous T lymphocytes engineered to co-express two chimeric antigen receptors (CARs)...
• Autologous anti-EGFRvIII 4SCAR-IgT cellsA preparation of autologous T cells that are genetically modified to express immunoglobulins (Igs) that...
• Autologous anti-EGFRvIII synNotch receptor-induced anti-EphA2/IL-13Ralpha2 CAR-T cellsA preparation of autologous T lymphocytes engineered to express a synthetic Notch (synNotch) receptor...
• Autologous anti-FcRL5 CAR-T cellsA preparation of autologous T lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting...
• Autologous anti-FGFR4 CAR T cellsA preparation of autologous T lymphocytes that have been genetically engineered to express a chimeric antigen...
• Autologous anti-FLT3 CAR T cells AMG 553A preparation of autologous T lymphocytes genetically engineered with a chimeric antigen receptor (CAR)...
• Autologous anti-FLT3 CAR T cells TAA05A preparation of autologous T lymphocytes genetically engineered with a chimeric antigen receptor (CAR)...
• Autologous anti-FLT3 CAR-T cells HG-CT-1A preparation of autologous T lymphocytes genetically modified with a chimeric antigen receptor (CAR)...
• Autologous anti-FSHR CER-4-1BB/CD3zeta-expressing T lymphocytesA preparation of autologous human T lymphocytes genetically modified to express a chimeric endocrine receptor...
• Autologous anti-GD2/anti-PSMA 4SCAR-expressing bispecific T cellsA preparation of autologous T lymphocytes that are genetically engineered to express a fourth-generation...
• Autologous anti-GD2-CAR-BBz-iCasp9 retroviral vector-transduced T lymphocytesA preparation of genetically modified autologous T lymphocytes transduced with a retroviral vector encoding a...
• Autologous anti-GD2CAR-CD28-CD3zeta-IL-15-expressing natural killer T cellsA preparation of autologous natural killer T lymphocytes (NKTs) that have been transduced with a retroviral...
• Autologous anti-GFRa4 CAR-TCR-zeta-4-1BB-expressing T cellsA preparation of autologous T lymphocytes that have been transduced with a lentiviral vector to express a...
• Autologous anti-glypican-3 CAR-IL-15-iC9-expressing T lymphocytesA preparation of T lymphocytes that have been genetically modified to express a chimeric antigen receptor...
• Autologous anti-gp100:154-162 T-cell receptor gene-engineered peripheral blood lymphocytesHuman autologous peripheral blood lymphocytes (PBLs) transduced with a glycoprotein 100 (gp100)...
• Autologous anti-gp100:154-162 TCR tumor infiltrating lymphocytesA preparation of human tumor infiltrating lymphocytes (TILs) isolated from a melanoma patient and engineered...
• Autologous anti-gp100CAR-CD3zeta-4-1BB-IL-15-PD1-expressing tri-functional T lymphocytesA preparation of autologous T lymphocytes that have been transduced with a lentiviral vector encoding a...
• Autologous anti-GPC2-CAR T cellsA preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous anti-GPC3 CAR T cells BOXR1030A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous anti-GPC3 CAR T lymphocytes JWAT204A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous anti-GPC3-CAR T lymphocytes Ori-C101A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous anti-GPRC5D CAR-T cells OriCAR-017A preparation of autologous T lymphocytes engineered to express a chimeric antigen receptor (CAR) specific...
• Autologous anti-GPRC5D-CAR-4-1BB-expressing T cells MCARH109A preparation of autologous T lymphocytes that have been transduced with a retroviral vector expressing a...
• Autologous anti-H3.3K27M TCR-expressing T cellsA preparation of autologous T lymphocytes that have been genetically engineered to express a T-cell receptor...
• Autologous anti-HER2 CAR macrophages CT-0508A preparation of autologous macrophages transduced with the adenoviral vector Ad5f35 to express a chimeric...
• Autologous anti-HER2 CAR monocytes CT-0525A preparation of autologous monocytes genetically modified to express a chimeric antigen receptor (CAR)...
• Autologous anti-HER2 CAR T cellsA preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous anti-HER2 CAR T cells CCT303-406A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous anti-HER2 CAR-CD28 T cellsA preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous anti-HER2 TAC T cells TAC01-HER2A preparation of autologous T lymphocytes that are genetically engineered with a T-cell Antigen Coupler...
• Autologous anti-HER2-CAR-4-1BB-CD3zeta-CD19t+-expressing Tcm-enriched T lymphocytesA preparation of genetically modified autologous central memory (Tcm) enriched T cells transduced with a...
• Autologous anti-HLA-A*0201/AFP CAR-T cells ET1402L1A preparation of autologous T lymphocytes that have been transduced with a lentiviral vector encoding a...
• Autologous anti-HLA-A*02/AFP TCRm-expressing T cells ET140202A preparation of autologous T lymphocytes that have been transduced with a lentiviral vector to express a...
• Autologous anti-HLA-G CAR-T cells IVS-3001A preparation of autologous T-lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous anti-HPV-16 E6 T-cell receptor gene-engineered peripheral blood lymphocytesHuman autologous peripheral blood lymphocytes (PBLs) transduced with a retroviral vector encoding a T-cell...
• Autologous anti-ICAM-1-CAR-CD28-4-1BB-CD3zeta-expressing T cells AIC100A preparation of autologous T lymphocytes that have been transduced with a lentiviral vector to express a...
• Autologous anti-IL-1RAP CAR T cells CCTx-001A preparation of autologous CD4+ and CD8+ T lymphocytes that have been transduced to express a chimeric...
• Autologous anti-ILT3 CAR T cellsA preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous anti-kappa light chain CAR-CD28-expressing T lymphocytesA preparation of autologous T lymphocytes (ATL) that have been genetically modified to express a chimeric...
• Autologous anti-KK-LC-1 TCR-expressing T cellsA preparation of autologous T lymphocytes that have been genetically engineered to express a T-cell receptor...
• Autologous anti-L1CAM-CAR-EGFRt-expressing T cellsA preparation of autologous human T lymphocytes expressing a chimeric antigen receptor (CAR) specific for the...
• Autologous Anti-LGR5 CAR-T Cells CNA3103A preparation of autologous T-lymphocytes transduced to express a chimeric antigen receptor (CAR) targeting...
• Autologous anti-LILRB4 CAR-T cellsA preparation of autologous T lymphocytes that have been genetically modified and transduced with a...
• Autologous anti-MAGE-A1 TCR-engineered T cells TSC-204-A0201A preparation of autologous T lymphocytes that are engineered to express a T-cell receptor (TCR) specific for...
• Autologous anti-MAGE-A1 TCR-engineered T cells TSC-204-C0702A preparation of autologous T lymphocytes that are engineered to express a T-cell receptor (TCR) specific for...
• Autologous anti-MART-1 F5 T-cell receptor gene-engineered peripheral blood lymphocytesHuman autologous peripheral blood lymphocytes (PBLs) transduced with a melanoma antigen MART-1...
• Autologous anti-MART-1 F5 TCR tumor infiltrating lymphocytesA preparation of human tumor infiltrating lymphocytes (TILs) isolated from a melanoma patient and engineered...
• Autologous anti-mesothelin CAR-CD3zeta-4-1-BB-expressing T cellsA preparation of autologous T lymphocytes transduced with a lentiviral vector expressing a chimeric antigen...
• Autologous anti-mesothelin CAR-IL-7-CCL19-expressing T lymphocytes TAK-103A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous anti-mesothelin CAR-T cells UCLM802A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous anti-mesothelin KIR-CAR-transduced T cells SynKIR-110A preparation of autologous T lymphocytes that have been genetically modified to express a killer cell...
• Autologous anti-mesothelin M28z1XXPD1DNR CAR-expressing T cellsA preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous anti-mesothelin T-cell receptor fusion construct/PD-1:CD28 switch receptor-expressing T cells TC-510A preparation of autologous T lymphocytes that have been genetically engineered to express a single-domain...
• Autologous anti-mesothelin TCR-expressing T cells FH-TCR TMSLNA preparation of autologous T lymphocytes that have been genetically engineered to express a T-cell receptor...
• Autologous anti-mesothelin TNhYP218 CAR T cellsA preparation of autologous T lymphocytes containing primarily naive and stem cell-like memory (scm) T cells...
• Autologous anti-MG7-CAR T lymphocytesA preparation of autologous, engineered T lymphocytes that express both a second-generation chimeric antigen...
• Autologous anti-MSLN CAR/HLA-A*02-gated inhibitory receptor/B2M shRNA-expressing T lymphocytes A2B694A preparation of autologous T lymphocytes that have been transduced with a lentiviral vector expressing an...
• Autologous anti-MUC16 CAR-mbIL15-safety switch T cells PRGN-3005A preparation of autologous T lymphocytes that have been genetically modified to co-express three transgenes...
• Autologous anti-MUC1*-CAR-4-1BB-CD3zeta-expressing T lymphocytesA preparation of autologous T lymphocytes transduced with a lentiviral vector encoding a human CD8 alpha...
• Autologous anti-Muc1/CD33/CD38/CD56/CD123 gene-engineered CAR-T cellsA preparation of genetically modified autologous T cells transduced with lentiviral vectors expressing...
• Autologous anti-NKG2D/anti-CLDN18.2 bispecific CAR T cells KD-496A preparation of autologous T lymphocytes that have been genetically modified to express a tandem chimeric...
• Autologous anti-NKG2DLs CAR-T cells LEU011A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous anti-NY-ESO-1 mTCR retroviral vector-transduced PBLsHuman autologous peripheral blood lymphocytes (PBLs) transduced with a retroviral vector encoding both alpha...
• Autologous anti-NY-ESO-1 TCR/CD8alpha-expressing T cells GSK3901961A preparation of human autologous T lymphocytes that are genetically modified to express a T-cell receptor...
• Autologous anti-NY-ESO-1 TCR/dnTGF-BRII-expressing T cells GSK3845097A preparation of human autologous T lymphocytes that are genetically modified to express a T-cell receptor...
• Autologous anti-PD-1 antibody-activated tumor-infiltrating lymphocytesA preparation of autologous tumor infiltrating lymphocytes (TILs) activated by an anti-programmed cell death...
• Autologous anti-PD-L1-armored anti-CD22 CAR T cellsA preparation of autologous T lymphocytes that have been genetically engineered to express a chimeric antigen...
• Autologous anti-PRAME TCR/CD8alphabeta-expressing T cells IMA203CD8A preparation of autologous T lymphocytes that are genetically modified with a lentiviral vector encoding a...
• Autologous anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T lymphocytesA preparation of autologous T lymphocytes that have been immunomagnetically depleted of CD14+ myeloid cells...
• Autologous anti-PSMA CAR T cells P-PSMA-101A preparation of autologous T cells that are enriched to be primarily stem memory T cells (Tscm) and are...
• Autologous anti-PSMA CAR/CD2/dnTGF-BRII/PD-1:CD28 switch receptor-expressing T cells TmPSMA-02A preparation of autologous T lymphocytes that have been genetically modified and transduced with a...
• Autologous anti-PSMA gene-modified T lymphocytesAutologous prostate specific membrane antigen (PSMA) gene-modified T lymphocytes with potential...
• Autologous anti-ROR1 CAR T cells LYL797A preparation of genetically and epigenetically reprogrammed autologous T lymphocytes transduced with a...
• Autologous anti-ROR1 CAR-mbIL15-safety switch/intrinsic PD-1 blockade T cells PRGN-3007A preparation of autologous T lymphocytes engineered to express, using a single non-viral multicistronic...
• Autologous anti-ROR1 CAR-T cells BMS-986403A preparation of autologous T lymphocytes genetically modified to express a chimeric antigen receptor (CAR)...
• Autologous anti-ROR1 CAR-T cells ONCT-808A preparation of autologous T lymphocytes transduced with a lentiviral vector to express a chimeric antigen...
• Autologous anti-siglec-6 CAR-T cellsA preparation of autologous T lymphocytes that have been genetically engineered to express a chimeric antigen...
• Autologous anti-SLAMF7 CAR-expressing T cellsA preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous anti-TIM-3/anti-CD123 CAR T cellsA preparation of autologous T cells engineered to express a chimeric antigen receptor (CAR) specific for the...
• Autologous anti-TM4SF1 CAR-T cellsA preparation of autologous T lymphocytes that have been genetically engineered to express a chimeric antigen...
• Autologous AXL-targeted CAR-T cells CCT301-38A preparation of genetically modified autologous T lymphocytes transduced with a lentiviral vector to express...
• Autologous B7-H3/EGFR806/HER2/IL13-zetakine CAR-expressing CD4+/CD8+ T cells SC-CAR4BRAINA preparation of autologous CD4+ and CD8+ T lymphocytes transduced with a lentiviral vector to express four...
• Autologous BAFF-expressing CAR T cells LMY-920A preparation of autologous cluster of differentiation 4 (CD4) -and CD8 positive T lymphocytes that are...
• Autologous BAFFR-targeting CAR T cellsA preparation of autologous T lymphocytes that are genetically engineered to express a chimeric antigen...
• Autologous base edited CD34+ HSPCs BEAM-101A population of autologous cluster of differentiation 34 (CD34)-positive human hematopoietic stem and...
• Autologous B-cell/monocyte-presenting HER2/neu antigen vaccine BVAC-BAn autologous vaccine composed of the antigen presenting cells (APCs) B lymphocytes and monocytes presenting...
• Autologous BCL11A-disrupted human hematopoietic stem and progenitor cells HIX763A population of autologous human hematopoietic stem and progenitor cells (HSPCs) that are genetically...
• Autologous BCMA-4-1BBz-targeted CAR T cellsA preparation of autologous T lymphocytes that have been ex vivo transduced with a retroviral vector...
• Autologous BCMA/TACI-targeted CAR T cells AUTO2A preparation of autologous T lymphocytes that are genetically engineered to contain a dual-targeted chimeric...
• Autologous BCMA/TACI-targeted trimeric APRIL-based CAR T cellsA preparation of autologous T lymphocytes that are genetically engineered to contain a dual-targeted chimeric...
• Autologous BCMA-targeted CAR T cells LCAR-B4822MA preparation of autologous peripheral blood T lymphocytes (PBTLs) that have been genetically modified to...
• Autologous BCMA-targeted CAR-T cells CC-98633A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous bispecific BCMA/CD19-targeted CAR T cells GC012FA preparation of autologous T lymphocytes engineered to express two separate chimeric antigen receptors...
• Autologous bispecific CD19/CD22-targeted CAR-T cells GC022FA preparation of autologous human T lymphocytes engineered to express chimeric T-cell receptors (chimeric...
• Autologous bladder cell carcinoma RNAs/CD40L RNA electroporated autologous matured dendritic cellsA cell-based preparation in which autologous, mature dendritic cells (DCs) are electroporated with in vitro...
• Autologous blinatumomab-expanded T cellsA preparation of autologous, peripheral blood-derived polyclonal activated T cells that have been expanded...
• Autologous bone marrowIn transplantation, refers to a person's own bone marrow. Bone marrow is the soft, sponge-like tissue in the...
• Autologous bone marrow transplantA procedure in which a patient’s healthy stem cells (blood-forming cells) are collected from the bone marrow...
• Autologous bone marrow-derived CD34/CXCR4-positive stem cells AMR-001A cell-based product containing autologous bone marrow derived CD34 positive and C-X-C chemokine receptor...
• Autologous CAR T cells KITE-197A preparation of autologous T lymphocytes that have been genetically engineered to express a chimeric antigen...
• Autologous CAR T cells RD14-01A preparation of autologous T lymphocytes that are genetically engineered to express a chimeric antigen...
• Autologous CAR T cells U87A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous CAR-CD28-expressing T lymphocytesA preparation of autologous T lymphocytes expressing a chimeric antigen receptor (CAR) specific for the...
• Autologous CAR-engineered regulatory T cells SBT777101A preparation of autologous T-regulatory cells (Tregs) that have been genetically modified to express a...
• Autologous CAR-mbIL15-safety switch T cells PRGN-3006A preparation of autologous T lymphocytes that have been genetically modified to co-express three transgenes...
• Autologous CAR-T cells B4T2-001A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous CCR4-CD30CAR-CD28-CD3zeta-expressing T lymphocytesA preparation of autologous T lymphocytes (ATL) that have been transduced with the retroviral vector SFG, a...
• Autologous CD123-4SCAR-expressing T cells 4SCAR123A preparation of genetically modified autologous T cells transduced with a replication incompetent...
• Autologous CD123CAR-CD28-CD3zeta-EGFRt-expressing T lymphocytesA preparation of genetically modified autologous T-cells transduced with a replication-incompetent...
• Autologous CD123CAR-CD28-CD3zeta-EGFRt-expressing T lymphocytes MB-102A preparation of genetically modified autologous T cells transduced with a replication incompetent...
• Autologous CD133-positive BTSC mRNA-pulsed autologous dendritic cell vaccineA cancer vaccine consisting of autologous dendritic cells (DCs) loaded with CD133-positive autologous brain...
• Autologous CD138-specific CAR T cellsA preparation of autologous T lymphocytes that have been engineered to express a chimeric antigen receptor...
• Autologous CD171-specific CAR-CD28 zeta-4-1-BB-EGFRt-expressing T lymphocytesA preparation of genetically modified autologous human T-lymphocytes transduced with a lentiviral vector...
• Autologous CD19 CAR+ EGFRt + CD4+ and CD8+ T cellsA preparation of a defined ratio of CD4+ and CD8+ autologous T lymphocytes transduced with a lentiviral...
• Autologous CD19 CAR-expressing CD4+/CD8+ T cells MB-CART19.1A preparation of CD4+ and CD8+ autologous T lymphocytes transduced with the lentiviral vector pLTG1563...
• Autologous CD19 CAR-expressing T cells YTB323A preparation of autologous T lymphocytes that are genetically engineered to express a chimeric antigen...
• Autologous CD19-28z chimeric antigen receptor-expressing T lymphocytesGenetically modified autologous T-lymphocytes transduced with a replication-incompetent retroviral vector...
• Autologous CD19CAR-CD28-CD137/CD27/CD3zeta-iCasp9-expressing T lymphocytesAutologous T lymphocytes that have been transduced with a fourth generation-lentiviral vector to express the...
• Autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cellsA preparation of genetically modified autologous central memory (Tcm) enriched T cells transduced with a...
• Autologous CD19/CD22 chimeric antigen receptor T cells CT120A preparation of autologous human T lymphocytes engineered to express a chimeric T-cell receptor (chimeric...
• Autologous CD19-CD8-CD28-CAR-mbIL15-HER1t T cellsA preparation of autologous T lymphocytes, that have been electroporated ex vivo with sleeping beauty...
• Autologous CD19-CD8-CD28-CD3zeta-CAR-mbIL15-HER1t T cellsA preparation of autologous, genetically modified T lymphocytes, that have been electroporated ex vivo with...
• Autologous CD19/PD-1 bispecific CAR-T cellsA preparation of autologous T lymphocytes that are transduced with a lentiviral vector encoding a chimeric...
• Autologous CD19-targeted CAR T cells CC 97540A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous CD19-targeted CAR-T cells GC007FA preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous CD20-4SCAR-expressing T cells 4SCAR20A preparation of genetically modified autologous T cells transduced with a replication incompetent...
• Autologous CD22-4SCAR-expressing T cells 4SCAR22A preparation of genetically modified autologous T cells transduced with a replication incompetent...
• Autologous CD30CAR-CD28-CD3zeta-expressing T lymphocytesA preparation of autologous T lymphocytes (ATL) that have been transduced with the retroviral vector SFG, a...
• Autologous CD34+ enriched alpha-L-iduronidase-expressing hematopoietic stem cells OTL-203A gene therapy agent composed of a preparation of autologous CD34-enriched hematopoietic stem cells (HSCs)...
• Autologous CD34+-enriched HSPCs transduced with lentiviral vector carrying FANCA gene RP-L102A preparation of autologous CD34+-enriched hematopoietic stem and progenitor cells (HSPCs) from mobilized...
• Autologous CD34+-enriched HSPCs transduced with LV vector carrying TCIRG1 gene RP-L401A preparation of autologous CD34+-enriched hematopoietic stem and progenitor cells (HSPCs) from mobilized...
• Autologous CD34+-enriched HSPCs transduced with VSV-G encoding IFN-a2A preparation of autologous CD34+-enriched hematopoietic stem and progenitor cells (HSPCs) that are...
• Autologous CD34-positive BCL11A-disrupted hematopoietic progenitor cells BIVV003A population of autologous cluster of differentiation 34 (CD34)-positive hematopoietic progenitor cells...
• Autologous CD34-positive BCL11A-disrupted hematopoietic progenitor cells ST-400A population of autologous CD34-positive, B-cell lymphoma/leukemia 11A (BCL11A)-disrupted hematopoietic...
• Autologous CD34-positive hematopoietic progenitor cellsA population of autologous CD34-positive hematopoietic progenitor cells (HPCs) that can be used for...
• Autologous CD34-positive peripheral blood stem cellsA population of autologous cluster of differentiation 34 (CD34)-positive peripheral blood stem cells (PBSCs)...
• Autologous CD38-4SCAR-expressing T cells 4SCAR38A preparation of genetically modified autologous T cells transduced with a replication incompetent...
• Autologous CD4- and CD8-positive truncated CD19-expressing antigen presenting T cellsA preparation of ex vivo expanded, autologous CD4 and CD8 positive antigen presenting T cells (T-APCs)...
• Autologous CD40L-expressing B-CLL vaccineA cancer vaccine consisting of autologous, B-chronic lymphocytic leukemia (B-CLL) cells harvested from a...
• Autologous CD4+/CD8+ 4-1BB-CD3zeta-EGFR806-CAR-EGFRt/4-1BB-CD3zeta- CD19-CAR-HER2tG-expressing CARs T cellsA preparation of CD4+ and CD8+ autologous T lymphocytes transduced with a lentiviral vector that co-expresses...
• Autologous CD4+/CD8+ EGFR806 specific 4-1BB-CD3zeta-EGFRt-expressing CAR T cellsA preparation of CD4+ and CD8+ autologous T lymphocytes transduced with a lentiviral vector expressing a...
• Autologous CD5KO anti-CD5 CAR 4-1BB-expressing T lymphocytes and autologous CD5KO T lymphocytesA dual-population preparation of autologous T lymphocytes in which the tumor-associated antigen (TAA) CD5 is...
• Autologous CD5-specific CAR-28 zeta CAR T cellsAutologous T lymphocytes transduced with a retroviral vector expressing a chimeric antigen receptor (CAR)...
• Autologous CD8+ melanoma-specific T cellsAutologous CD8 T lymphocytes against melanoma-associated antigens, with potential immunomodulating and...
• Autologous CD8+ SLC45A2-specific T lymphocytesA preparation of autologous CD8+ T lymphocytes targeting SLC45A2, a melanoma-associated antigen, with...
• Autologous CD8-positive PBL sensitized to Drosophila cell-presented melanoma peptidesA preparation of autologous CD8+ (cytotoxic) human peripheral blood lymphocytes (PBLs) sensitized to...
• Autologous CEA-specific cytotoxic T-lymphocytesAutologous cytotoxic T-lymphocytes (CTLs) specifically reactive to the tumor-associated antigen (TAA) human...
• Autologous cervical cancer-specific engineered immune effector cellsA preparation of autologous immune effector cells genetically modified to target a not yet disclosed cervical...
• Autologous CISH-inactivated TILsA preparation of autologous tumor-infiltrating lymphocytes (TILs) where the cytokine-inducible SH2-containing...
• Autologous CLL1-CD33 compound CAR T cellsAutologous T lymphocytes transduced with a lentiviral vector expressing a compound chimeric antigen receptor...
• Autologous clonal neoantigen T cells ATL001A preparation of personalized tumor-derived T-lymphocytes composed of tumor infiltrating lymphocytes (TILs)...
• Autologous CLTX-targeted CAR T lymphocytes CHM 1101A preparation of autologous T lymphocytes genetically modified to express a chimeric antigen receptor (CAR)...
• Autologous c-Met/PD-L1-specific CAR T cellsA preparation of autologous T lymphocytes that have been transduced with a lentiviral vector encoding a...
• Autologous CMV pp65/total tumor mRNA-loaded lipid particle vaccineAn mRNA-based, personalized cancer vaccine consisting of total tumor RNA (TTRNA) derived and amplified from...
• Autologous CMV-pp65-flLAMP mRNA-loaded dendritic cell vaccineA cancer cell vaccine consisting of autologous dendritic cells (DCs) loaded with mRNA encoding the human...
• Autologous CMV-pp65-LAMP mRNA-loaded monocyte vaccine MT-201-GBMA cancer cell vaccine consisting of autologous monocytes loaded with mRNA encoding the human cytomegalovirus...
• Autologous CMV-pp65-shLAMP-1 mRNA loaded dendritic cell vaccineA cancer cell vaccine consisting of autologous dendritic cells pulsed with mRNA encoding the human...
• Autologous colon cancer cell vaccineA personalized, proprietary cancer vaccine composed of sterile, irradiated, non-dividing, live colon cancer...
• Autologous colorectal tumor antigen-pulsed dendritic cell vaccineA dendritic cell (DC)-based cancer vaccine composed of autologous DCs pulsed with tumor cell lysates from a...
• Autologous CRISPR-Cas9 engineered regnase-1/SOCS1 dual-edited tumor infiltrating lymphocytes KSQ-004EXA preparation of autologous tumor infiltrating lymphocytes (TILs) gene-edited with the clustered regularly...
• Autologous CRISPR-Cas9 engineered tumor infiltrating lymphocytes KSQ-001EXA preparation of autologous tumor infiltrating lymphocytes (TILs) gene-edited with the clustered regularly...
• Autologous CRISPR-Cas9-modified/BCL11A enhancer-disrupted CD34-positive human hematopoietic stem and progenitor cells CTX001A population of autologous cluster of differentiation 34 (CD34)-positive human hematopoietic stem and...
• Autologous CRISPR-Cas9-modified/BCL11A gene-disrupted human hematopoietic stem and progenitor cells OTQ923A population of autologous cluster of differentiation 34 (CD34)-positive human hematopoietic stem and...
• Autologous CRISPR-edited Anti-CD19 CAR T Cells XYF19A preparation of autologous T-lymphocytes transduced with a lentiviral vector encoding a chimeric antigen...
• Autologous CRISPR-edited tumor infiltrating lymphocytes GT316A preparation of autologous tumor-infiltrating lymphocytes (TILs) derived from each patient's resected tumor...
• Autologous CT7/MAGE-A3/WT1 mRNA-electroporated Langerhans-type dendritic cellsAn autologous tumor cell vaccine containing CD34+ hematopoietic progenitor cell (HPC)-derived Langerhans-type...
• Autologous CT-RCC-1 HERV-E-TCR-transduced-HLA-A11-restricted CD8+/CD34t+ T cellsA preparation of autologous T lymphocytes transduced with a retroviral vector encoding a T-cell receptor...
• Autologous cultured acute myeloid leukemia-specific cytotoxic T lymphocytesA preparation of cytotoxic, autologous acute myelogenous leukemia (AML)-reactive T lymphocytes (CTL), with...
• Autologous CXCR2-modified CD70 CAR T cellsA preparation composed of ex-vivo expanded CXC chemokine receptor 2 (CXCR2) modified patient-derived...
• Autologous cytokine-induced killer cellsA proprietary formulation of autologous cytokine-induced killer (CIK) T lymphocytes, with immunopotentiating...
• Autologous cytokine-induced killer cells/vaccinia virus DD-CDSR CRX100A preparation of autologous cytokine-induced killer (CIK) cells that have been generated ex vivo from killer...
• Autologous cytomegalovirus-specific cytotoxic T lymphocytesA population of autologous cytotoxic lymphocytes (CTLs) specifically reactive to the herpes virus...
• Autologous cytoplasmic activated PD-1 CAR-TcellsA preparation of autologous T lymphocytes engineered to express a chimeric antigen receptor (CAR) specific...
• Autologous cytotoxic T lymphocytes exposed to dendritic cells loaded with 6B11 anti-idiotype minibodyA preparation of autologous cytotoxic T lymphocytes (CTLs) that are exposed, ex vivo, to autologous dendritic...
• Autologous cytotoxic T lymphocytes induced with MUC1 gene-transfected dendritic cellsA preparation of autologous cytotoxic T-lymphocytes (CTL), specifically reactive to the tumor-associated...
• Autologous cytotoxic T lymphocytes induced with MUC1 peptide-transfected dendritic cellsA preparation of autologous cytotoxic T-lymphocytes (CTL), specifically reactive to the tumor-associated...
• Autologous deep IL-15 primed T cells TRQ15-01A preparation of genetically modified, multi-antigen-directed autologous T lymphocytes, that have particles...
• Autologous dendritic cell vaccine ACT2001A cell-based cancer vaccine composed of autologous, immature dendritic cells (DCs), with potential...
• Autologous dendritic cell-adenovirus CCL21 vaccineA cancer vaccine comprised of autologous dendritic cells (DCs) that have been transduced ex vivo with an...
• Autologous dendritic cell-adenovirus p53 vaccineAn autologous vaccine composed of dendritic cells (DC) that have been transduced with a p53 tumor suppressor...
• Autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccineA cell-based vaccine composed of autologous dendritic cells (DCs) pulsed with lysates from heat-treated...
• Autologous dendritic cell-autologous tumor mRNA-human CD40L vaccineA cancer vaccine consisting of autologous dendritic cells transfected with autologous tumor mRNA and the...
• Autologous dendritic cell/myeloma fusion vaccineA therapeutic cancer vaccine consisting of autologous dendritic cells (DCs) fused with patient-derived plasma...
• Autologous dendritic cells pulsed with MART-1 (26-35) peptideA cell-based vaccine consisting of autologous HLA-A2*0201-restricted dendritic cells (DC), which were derived...
• Autologous dendritic cells transduced with wild-type p53 adenovirus vaccineA cancer vaccine consisting of autologous dendritic cells (DCs) transduced with a recombinant...
• Autologous dendritic cell-tumor fusion vaccineA therapeutic cancer vaccine consisting of autologous dendritic cells (DCs) fused with autologous tumor cells...
• Autologous desmoglein-3 chimeric autoantibody receptor T cells DSG3-CAARTA preparation of autologous T lymphocytes that have been engineered to express a chimeric autoantibody...
• Autologous dinitrophenyl-modified ovarian cancer vaccineA cancer vaccine consisting of autologous ovarian cancer cell peptide antigens conjugated to the hapten...
• Autologous dnTGF-BRII-armored anti-GPC3 CAR T cells AZD5851A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous dnTGF-BRII-armored anti-STEAP2 CAR T cells AZD0754A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous E6 T cell receptor genetically-modified T cellsA preparation of human autologous peripheral blood lymphocytes (PBLs) that have been genetically engineered...
• Autologous EBV-CTL CD19CAR zetaAutologous Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes (CTL) that have been genetically...
• Autologous EBV-transformed B lymphoblastoid-tumor fusion cell vaccineA cell-based vaccine composed of autologous tumor cells fused with Epstein-Barr virus-transformed...
• Autologous EGFR-specific CAR-T cells expressing anti-PD-1/CTLA-4 antibodiesA preparation of autologous T lymphocytes that have been activated and genetically modified to express immune...
• Autologous EGFRt/19-28z/4-1BBL CAR T lymphocytesGenetically modified autologous T lymphocytes transduced with a replication incompetent retroviral vector...
• Autologous EGFRt/BCMA-41BBz-targeted CAR T cellsA preparation of autologous T lymphocytes transduced with a retroviral vector expressing a chimeric antigen...
• Autologous engineered TCR-T cells KSH01A preparation of autologous T lymphocytes genetically modified to express a T-cell receptor (TCR) specific...
• Autologous engineered TCR-T cells KSX01A preparation of autologous T lymphocytes genetically modified to express a T-cell receptor (TCR) specific...
• Autologous enhanced NY-ESO-1 TCR engineered T cells GSK4427296A preparation of human autologous engineered T lymphocytes that express an affinity-enhanced T-cell receptor...
• Autologous Epstein-Barr virus-specific cytotoxic T lymphocytesA preparation of lymphocytes harvested from a patient with an Epstein-Barr virus (EBV)-positive tumor. Ex...
• Autologous Epstein-Barr virus-transformed B-lymphoblastoid cell vaccineA cell-based vaccine composed of autologous lymphoblastoid B cells activated against Epstein-Barr virus (EBV)...
• Autologous expanded mesenchymal stem cells OTI-010A product that is made of special stem cells taken from a patient’s bone marrow and grown in the laboratory...
• Autologous follicular lymphoma-derived idiotype vaccineA patient-specific cancer vaccine directed against the soluble protein idiotype of an individual follicular...
• Autologous FRa-4SCAR-expressing T cells 4SCAR-FRaA preparation of genetically modified autologous T cells transduced with a replication incompetent...
• Autologous gamma delta T-cell receptor-expressing T cells TEG002A preparation of autologous T lymphocytes genetically engineered to express a defined gamma delta T-cell...
• Autologous gamma-globinG16D/sh RNA734 gene-transduced CD34-positive cells CSL200A preparation of autologous, CD34-positive hematopoietic stem cells (HSCs) transduced ex vivo with a...
• Autologous gamma-retroviral MSGV1 139 scFv EGFRvIII CAR gene-modified T cellsA preparation of autologous T lymphocytes transduced with the gamma retroviral vector MSGV1 expressing a...
• Autologous GCC-targeting CAR T Cells GCC19CARTA preparation of autologous T lymphocytes that are genetically engineered to express a chimeric antigen...
• Autologous GCC-targeting CAR T cells LCAR-G08A preparation of autologous T lymphocytes that are genetically engineered, using a lentiviral vector, to...
• Autologous gene-modified gamma delta T cellsA preparation of genetically modified autologous gamma delta T lymphocytes transduced with a lentiviral...
• Autologous gene-modified PD-1-positive T lymphocytes Sc610A preparation of autologous programmed cell death protein 1 (PD-1; PDCD1; CD279)-positive T lymphocytes...
• Autologous gene-modified PD-1-positive T lymphocytes ScTIL210A preparation of autologous programmed cell death protein 1 (PD-1; PDCD1; CD279)-positive T lymphocytes...
• Autologous genetically-modified MAGE-A4 C1032 CD8alpha T cellsAutologous human T lymphocytes transduced with a retroviral vector encoding a T-cell receptor (TCR) specific...
• Autologous glioma cell lysateA cell lysate derived from glioma cells with potential immunostimulatory and antineoplastic activities. Upon...
• Autologous GM-CSF-secreting breast cancer vaccineAn autologous tumor cell vaccine containing irradiated breast cancer cells transfected with the granulocyte...
• Autologous GM-CSF-secreting lethally irradiated colorectal cancer cell vaccineA lethally irradiated, autologous colorectal cancer vaccine consisting of patient-specific colorectal cancer...
• Autologous GM-CSF-secreting lethally irradiated leukemia cell vaccineAn autologous cancer vaccine composed of lethally irradiated leukemia cells that are genetically modified to...
• Autologous GM-CSF-secreting lethally irradiated lung cancer vaccineAn autologous lung cancer vaccine consisting of patient-specific lung cancer cells genetically modified to...
• Autologous GM-CSF-secreting lethally irradiated pancreatic cancer vaccineAn irradiated, autologous pancreatic cancer vaccine consisting of patient-specific pancreatic cancer cells...
• Autologous GPC3/NY-ESO-1/AFP-specific CD8-positive T lymphocytesA preparation of autologous CD8-positive T lymphocytes that are exposed, ex vivo, to multiple specific...
• Autologous HBV-specific TCR-expressing T lymphocytes SCG101A preparation of human autologous T lymphocytes transduced with a retroviral vector encoding for a T-cell...
• Autologous HBV-specific TCR-redirected T lymphocytesA preparation of human autologous T-lymphocytes transduced with a viral vector encoding for a T cell receptor...
• Autologous heat-shock protein 70 peptide vaccine AG-858A recombinant cancer vaccine made with tumor-derived heat shock protein 70 (HSP70) peptide complexes. HSP70...
• Autologous HER2-CAR-modified adenovirus-specific cytotoxic T lymphocytesA population of autologous cytotoxic T lymphocytes (CTLs) specifically reactive to human adenovirus (Ad) that...
• Autologous HER2-specific/EGFRt-expressing CD4/CD8-positive CAR T cellsA preparation of CD4+ and CD8+ autologous T lymphocytes transduced with a lentiviral vector expressing a...
• Autologous HER2-targeted dual-switch CAR T cells BPX-603A preparation of autologous T lymphocytes that express a chimeric antigen receptor (CAR) for the human...
• Autologous HIV Gag-specific CD4+ T cells AGT103-TA preparation of autologous, human immunodeficiency virus (HIV) Gag-specific, cluster of differentiation 4...
• Autologous HLA-A*11:01 KRASG12V-specific TCR-expressing CD8- and CD4-positive T lymphocytes AFNT-211A preparation of autologous HLA class I histocompatibility antigen A*11:01 (HLA-A1101)-positive CD8- and...
• Autologous HNSCC DNA-transfected semi-allogeneic fibroblasts MRC-5 vaccineA vaccine consisting of lethally irradiated human fetal lung fibroblasts (Medical Research Council 5 or...
• Autologous HPV16 E7-specific HLA-A*02:01-restricted TCR gene engineered lymphocytes KITE-439A preparation of autologous T lymphocytes that have been genetically modified to express a T-cell receptor...
• Autologous HPV-16/18 E6/E7-specific TGF-beta-resistant T lymphocytesA preparation of autologous transforming growth factor-beta (TGF-beta)-resistant cytotoxic T-lymphocytes...
• Autologous HPV16/HPV18/Survivin-specific CD8+ T cells NEXI-003A preparation of autologous CD3+ CD4- CD8+ T cells targeting multiple human papilloma virus (HPV)...
• Autologous HPV-E6/E7-targeting T cellsA preparation of autologous T lymphocytes that are specifically reactive towards the human papillomavirus...
• Autologous HPV-specific cytotoxic T lymphocytesA population of autologous cytotoxic T lymphocytes (CTLs) that are specifically reactive to human...
• Autologous human anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ T lymphocytesA preparation of a defined ratio of CD4+ and bulk CD8+ autologous T lymphocytes transduced with a lentiviral...
• Autologous iC9-deltaNGFR-CD19CAR-CD3zeta-4-1BB-expressing T lymphocytesA preparation of autologous T lymphocytes that have been transduced with a retroviral vector to express a...
• Autologous iC9-GD2CAR-CD28-CD3zeta-IL-15-expressing T lymphocytesA preparation of autologous T lymphocytes that have been transduced with the retroviral vector SFG, a Moloney...
• Autologous iC9-GD2-CAR-expressing VZV-specific T lymphocytesGenetically modified, autologous varicella zoster virus (VZV)-specific T-lymphocytes transduced with a...
• Autologous iCASP9-CD19-expressing T lymphocytesA preparation of autologous T lymphocytes that are transduced with a retroviral vector encoding a chimeric...
• Autologous iCasp9-deltaNGFR-CD19CAR-expressing T cellsA preparation of autologous T lymphocytes that are transduced with a retroviral vector encoding a chimeric...
• Autologous IL-12/multi-targeted primed T cells RPTR 168A preparation of genetically modified, multi-antigen-targeted autologous T lymphocytes, tethered with the...
• Autologous IL-15-expanded HER2-specific CD4+ T cellsA preparation of autologous, interleukin-15 (IL-15)-expanded, human epidermal growth factor receptor 2...
• Autologous IL-15/IL-21-armored anti-glypican-3 CAR T cellsA preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous IL-21-modulated CD8+ MART1-specific T cellsA preparation of interleukin 21 (IL-21) stimulated, CD8+ T-lymphocytes sensitized to MART-1 (melanoma antigen...
• Autologous IL-2-expressing B-CLL vaccineA cancer vaccine consisting of autologous, B-chronic lymphocytic leukemia (B-CLL) cells harvested from a...
• Autologous IL-7/CCL19-expressing anti-GM2 CAR T cells NIB-101A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous IL-7-expanded HER2-specific CD4+ T cellsA preparation of autologous, interleukin-7 (IL-7)-expanded, human epidermal growth factor receptor 2 (EGFR2...
• Autologous IL-7-expressing TILs ADP-TILIL7A preparation of autologous tumor infiltrating lymphocytes (TILs) engineered to express the cytokine...
• Autologous IL-7Ra-expressing Tris-CAR T cellsA preparation of autologous T lymphocytes that have been genetically modified and lentivirally transduced to...
• Autologous immunoglobulin idiotype-KLH conjugate vaccineA cancer vaccine composed of tumor-specific idiotype determinants derived from an individual's tumor cells...
• Autologous interferon-producing killer dendritic cellsA preparation of autologous dendritic cells (DC) with a molecular expression profile similar to both natural...
• Autologous interleukin-15-armored anti-glypican-3 CAR-iC9-expressing T lymphocytesA preparation of T lymphocytes that have been genetically modified to express a chimeric antigen receptor...
• Autologous KRAS G12D mutant-specific HLA-C*08:02-/KRAS G12D mutant-specific HLA-A*11:01-/KRAS G12V mutant-specific HLA-C*01:02-/TP53 R175H mutant-specific HLA-A*02:01-restricted TCR genes engineered T lymphocytesA preparation of autologous T lymphocytes that have been genetically modified to express a T-cell receptor...
• Autologous KRAS G12D-specific HLA-C*08:02-restricted TCR gene engineered T lymphocytes NT-112A preparation of autologous T lymphocytes that have been genetically modified to express a T-cell receptor...
• Autologous LMP1-/LMP2- specific cytotoxic T-lymphocytesA preparation of cytotoxic T-lymphocytes (CTL), specifically reactive to the Epstein-Barr virus (EBV) latent...
• Autologous LMP1/LMP2/EBNA1-specific HLA-A02:01/24:02/11:01-restricted TCR-expressing T lymphocytes YT-E001A preparation of autologous T lymphocytes that have been transduced with a lentiviral vector encoding a...
• Autologous lymphocyteIn transplantation, refers to a person’s own white blood cells. Lymphocytes have a number of roles in the...
• Autologous lymphoid effector cells specific against tumor cellsA preparation of cytotoxic, autologous lymphoid effector cells specifically targeted towards tumor cells...
• Autologous lymphoma cell lysate-pulsed autologous dendritic cell vaccineA cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with lysate from autologous...
• Autologous lymphoma cell/allogeneic dendritic cell electrofusion hybrid vaccineA cell-based cancer vaccine consisting of hybrid cells created by electrofusing allogeneic dendritic cells...
• Autologous lymphoma cell/autologous dendritic cell electrofusion hybrid vaccineA cell-based cancer vaccine consisting of hybrid cells created by electrofusing autologous dendritic cells...
• Autologous lymphoma immunoglobulin-derived scFV-chemokine DNA vaccineA plasmid DNA vaccine encoding an autologous lymphoma-derived idiotype-targeting immunoglobulin (Ig)-derived...
• Autologous MAGE-A10-specific HLA-A2-restricted TCR c796 gene-engineered lymphocytesHuman autologous T lymphocytes transduced with a retroviral vector encoding a high-affinity T-cell receptor...
• Autologous MAGE-A3/A6-specific TCR gene-engineered lymphocytes KITE-718Human autologous T lymphocytes genetically modified to express a T-cell receptor (TCR) that specifically...
• Autologous MAGE-A3-specific HLA-A*01-restricted T cell receptor gene engineered lymphocytesHuman autologous T lymphocytes transduced with a retroviral vector encoding a T-cell receptor (TCR) specific...
• Autologous MAGE-C2-specific HLA-A2-restricted TCR T lymphocytesA preparation of autologous T lymphocytes genetically modified to express a T-cell receptor (TCR) specific...
• Autologous mbIL-12-expressing tumor infiltrating lymphocytes GT202A preparation of autologous tumor infiltrating lymphocytes (TILs) engineered to express membrane-bound...
• Autologous MCPyV-specific HLA-A02-restricted TCR-transduced CD4+ and CD8+ T cells FH-MCVA2TCRA preparation of autologous CD4+ and CD62L-expressing CD8+ T cells transduced with a third generation...
• Autologous mDC3 vaccineAn antineoplastic vaccine composed of autologous mature dendritic cells (mDCs) pulsed with mutated peptides...
• Autologous mDC3/8-KRAS vaccineAn antineoplastic vaccine composed of autologous mature dendritic cells (mDCs) pulsed with mutant KRAS...
• Autologous melanoma lysate/KLH-pulsed autologous dendritic cell vaccineA cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with lysate from autologous...
• Autologous melanoma lysate/NY-ESO-1-pulsed autologous dendritic cell vaccineA cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with both a lysate from...
• Autologous melanoma lysate-pulsed autologous dendritic cell vaccineA cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with lysate from autologous...
• Autologous memory cytokine-enriched natural killer cellsA population of cryopreserved, autologous CD56-positive memory cytokine-enriched natural killer (NK) cells...
• Autologous mesenchymal stem cells apceth_101Human autologous mesenchymal stem cells (MSCs) harvested from the bone marrow of a patient and genetically...
• Autologous mesenchymal stem cells-poly lactic-co-glycolic acidA preparation of autologous bone marrow derived mesenchymal stem cells (MSC) that are seeded on biodegradable...
• Autologous mesothelin-specific CAR-T cellsGenetically modified, autologous T lymphocytes transduced with a gene encoding a chimeric antigen receptor...
• Autologous mesothelin-specific CAR-T cells expressing anti-PD-1/CTLA-4 antibodiesA preparation of autologous, engineered T lymphocytes that express both a second-generation chimeric antigen...
• Autologous mesothelin-specific human mRNA CAR-transfected PBMCs MCY-M11Autologous peripheral blood mononuclear cells (PBMCs) transfected with anti-mesothelin chimeric antigen...
• Autologous MG-7-pulsed dendritic cell vaccineA dendritic cell (DC)-based cancer vaccine composed of autologous DCs pulsed with the human gastric...
• Autologous MGMTP140K lentiviral vector-transduced HSCsA preparation of autologous CD34+ hematopoietic stem cells (HSCs) transduced with a lentiviral-based proviral...
• Autologous monocyte-derived lysate-pulsed dendritic cells PV-001-DCA cell-based cancer vaccine composed of autologous, monocyte-derived dendritic cells (mDCs) pulsed with tumor...
• Autologous mRNA-encoding NSCLC neoantigens dendritic cell vaccineA dendritic cell (DC) - based cancer vaccine in which the autologous, in vitro activated DCs are loaded with...
• Autologous mRNA-modified anti-cMET CAR-T cellsA preparation of autologous, genetically-engineered T lymphocytes that have been electroporated with an mRNA...
• Autologous mRNA-transfected anti-BCMA-CAR T lymphocytes SYS6020A preparation consisting of autologous T lymphocytes that have been transfected with lipid nanoparticle...
• Autologous MUC1-activated T cellsA preparation of autologous T lymphocytes that have been activated against the tumor associated antigen (TAA)...
• Autologous MUC1-mannan fusion protein pulsed dendritic cell vaccineA cancer vaccine containing autologous dendritic cells pulsed with a fusion product of an epitope of human...
• Autologous multi-lineage potential cellsA preparation of autologous multi-lineage potential cells (AMPC) which were induced to de-differentiate from...
• Autologous multiple antigen-specific T cells MASE-TA preparation of autologous T cells targeting multiple antigens expressed by melanoma cells, with potential...
• Autologous muscle-derived cells for gastrointestinal repairA preparation of autologous human muscle-derived stem cells (MDSCs), that can potentially be used for...
• Autologous MuSK-CD3z/4-1BB-expressing chimeric autoantibody receptor T cells MuSK-CAARTA preparation of autologous T lymphocytes that have been engineered to express a chimeric autoantibody...
• Autologous native ESR1-pulsed DC1 vaccine alternating with autologous mutated ESR1-pulsed DC1 vaccineA dendritic cell (DC)-based cancer vaccine composed of autologous, type-1 polarized dendritic cells (DC1s)...
• Autologous natural killer cell-like CTLsA preparation of cytotoxic T lymphocytes (CTLs) that express natural killer (NK)-like features (nCTLs), with...
• Autologous natural killer cells SNK01A preparation of autologous, ex-vivo expanded and activated natural killer (NK) cells, with potential...
• Autologous nectin-4/FAP-targeted CAR-T cellsA preparation of autologous T lymphocytes engineered to express a chimeric antigen receptor (CAR) specific...
• Autologous neoantigen-specific T lymphocytes GEN-011A preparation of autologous, personalized, immunogenic and tumor neoantigen-specific T lymphocytes, with...
• Autologous neuroblastoma lysate/KLH-pulsed dendritic cell vaccineA cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with a cell lysate from an...
• Autologous NKG2D CAR T cells KD-025A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous NKG2D CAR-CD3zeta-DAP10-expressing T lymphocytes CYAD-01A preparation of autologous peripheral blood T lymphocytes (PBTLs) that have been genetically modified and...
• Autologous NKG2D CAR-expressing T lymphocytes ASP2802A preparation of autologous T lymphocytes that are genetically modified to express a chimeric antigen...
• Autologous NKG2D CAR-T cells CYAD-02A preparation of autologous T lymphocytes that have been genetically modified and transduced with a...
• Autologous NSCLC DNA-transfected semi-allogeneic fibroblasts MRC-5 vaccineA vaccine consisting of irradiated human fetal lung fibroblasts (Medical Research Council 5 or MRC-5)...
• Autologous NSCLC peptide-specific dendritic cell vaccineA personalized cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with immunogenic...
• Autologous NY-ESO-1 TCR-targeted T lymphocytesA preparation of human autologous T lymphocytes that are transduced with a gene encoding a T-cell receptor...
• Autologous NY-ESO-1/LAGE-1a-specific HLA-A*02:01-restricted TCR-expressing T lymphocytes MDG1015A preparation of autologous T lymphocytes that have been genetically engineered to express a T-cell receptor...
• Autologous NY-ESO-1-melanoma-specific CD8+ T lymphocytesA preparation of autologous CD8+ (cytotoxic) T lymphocytes sensitized to cancer-testis antigen NY-ESO-1...
• Autologous NY-ESO-1-redirected CRISPR-edited T cellsA preparation of human autologous T lymphocytes that are transduced with a lentiviral vector (LV) encoding a...
• Autologous NY-ESO-1-specific CD8-positive T lymphocytesA preparation of autologous CD8+ T lymphocytes specifically reactive to the cancer-testis antigen NY-ESO-1...
• Autologous OFA-iLRP RNA-transfected dendritic cell vaccineA cancer vaccine consisting of autologous, mature monocyte-derived dendritic cells (DCs) transfected with...
• Autologous orthogonal IL-2Rbeta-expressing anti-CD19 CAR T cells SYNCAR-001A preparation of autologous T lymphocytes that have been genetically modified and transduced with a...
• Autologous ovarian cancer immunogene-modified T lymphocytesA preparation of autologous immunogene modified T lymphocytes (IgT) that have been genetically engineered to...
• Autologous ovarian cancer-specific antigens-pulsed dendritic cells Cellgram-DCA cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with ovarian cancer-specific...
• Autologous ovarian cancer-specific cytotoxic T lymphocytesA preparation of autologous cytotoxic T lymphocytes (CTLs) genetically modified to target a not yet disclosed...
• Autologous ovarian tumor cell lysate-pulsed dendritic cell vaccineA cell-based cancer vaccine composed of autologous, irradiated dendritic cells (DCs) pulsed with ovarian...
• Autologous oxidized ovarian tumor cell lysate vaccineAn autologous cancer vaccine composed of oxidized ovarian tumor cell lysate, with potential immunostimulatory...
• Autologous pancreatic adenocarcinoma lysate- and mRNA-loaded dendritic cell vaccineA cell-based cancer vaccine composed of autologous dendritic cells (DCs) loaded with pancreatic...
• Autologous PBLs retrovirally-transduced with TCRs targeting neoantigensAutologous human peripheral blood lymphocytes (PBLs) transduced with a retroviral vector encoding T-cell...
• Autologous PBMC-derived engineered leukocyte immunostimulatory cells-activated effector cellsA preparation of cytotoxic, autologous effector cells specifically targeted towards tumor cells and comprised...
• Autologous PBMCs in GM-CSFAutologous peripheral blood mononuclear cells (PBMCs) that are suspended in a solution containing the...
• Autologous PBTL CD19CAR-28 zetaA preparation of autologous peripheral blood T lymphocytes (PBTL) that have been genetically modified to...
• Autologous PD-1 antibody-expressing mesothelin-specific CAR-T cellsGenetically modified, autologous T lymphocytes that express an antibody that targets the negative...
• Autologous PD-1 nanobody-expressing anti-MSLN CAR T cellsA preparation of autologous T lymphocytes that have been genetically modified to express a nanobody that...
• Autologous PD1-inhibiting anti-CD19 4-1BB CAR T cellsA preparation of autologous T lymphocytes that are transduced with a lentiviral vector encoding a chimeric...
• Autologous PD1-knockout CD19-specific CAR T cellsA preparation of autologous CD4+ and CD8+ T lymphocytes gene-edited to integrate a chimeric antigen receptor...
• Autologous PD1-knockout CD19-specific CAR T cells BRL-201A preparation of autologous T lymphocytes that are non-virally gene-edited with the clustered regularly...
• Autologous PD-1-knockout tumor-infiltrating lymphocytes IOV-4001A preparation of autologous tumor-infiltrating lymphocytes (TILs) where the programmed cell death protein 1...
• Autologous PD-1-targeted chimeric switch receptor-modified T lymphocytesAutologous human T lymphocytes that are genetically engineered to express a chimeric switch receptor (CSR)...
• Autologous PD-L1/CD80/CD86-targeted CAR-T cellsA preparation of autologous human T lymphocytes engineered to express a chimeric antigen receptor (CAR)...
• Autologous peripheral blood lymphocytes cotransduced with retroviral vectors encoding inducible IL-12 and anti-NY-ESO-1 TCRHuman autologous peripheral blood lymphocytes (PBLs) transduced with two retroviral vectors, one encoding a...
• Autologous peripheral blood lymphocytes from ibrutinib-treated chronic lymphocytic leukemia patients IOV-2001A preparation of autologous peripheral blood lymphocytes (PBLs) harvested from chronic lymphocytic leukemia...
• Autologous pluripotent ALDHbr stem cells ALD-451A specific population of autologous, pluripotent bone marrow derived cells that express high levels of the...
• Autologous polyclonal tumor infiltrating lymphocytes LYL845A preparation of autologous, epigenetically reprogrammed, polyclonal tumor infiltrating lymphocytes (TILs)...
• Autologous PRAME-targeting TCR-engineered T cells IMA203A preparation of autologous T lymphocytes that are genetically modified with a lentiviral vector encoding a...
• Autologous PRAME-targeting TCR-modified T cells MDG1011Human autologous T lymphocytes transduced with a retroviral vector encoding a human leukocyte antigen...
• Autologous prostate cancer antigen-expressing dendritic cell vaccine BPX-101A genetically-modified autologous dendritic cell-based vaccine expressing a drug-inducible costimulatory CD40...
• Autologous prostate cancer-specific antigens-pulsed dendritic cells Cellgram-DC-PCA cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with prostate cancer...
• Autologous prostate stem cell antigen-specific CAR T cells BPX-601A preparation of autologous T lymphocytes expressing a chimeric antigen receptor (CAR) consisting of an...
• Autologous PSMA-4SCAR-expressing T cells 4SCAR-PSMAA preparation of genetically modified autologous T cells transduced with a replication incompetent...
• Autologous PSMA-inducible anti-CA9 CAR T cells AB-2100A preparation of autologous T lymphocytes that have been modified to encode a genetic circuit consisting of a...
• Autologous PSMA-specific TGFβ-resistant CAR T cellsAutologous T lymphocytes transduced with a lentiviral vector expressing a chimeric antigen receptor (CAR)...
• Autologous rapamycin-resistant Th1/Tc1 cells RAPA-201A preparation of autologous rapamycin-resistant Th1/Tc1 cells, with potential immunomodulating activity. Upon...
• Autologous renal cell carcinoma tumor lysate-pulsed dendritic cell vaccineA cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with renal cell carcinoma...
• Autologous retroviral vector MSGV1-transduced anti-PSCA-8T28Z CAR gamma delta T cellsA preparation of autologous gamma delta T lymphocytes transduced with the gamma retroviral vector MSGV1...
• Autologous ROR2-targeted CAR-T cells CCT301-59A preparation of genetically modified autologous T lymphocytes transduced with a lentiviral vector to express...
• Autologous sarcoma cell lysateA cell lysate derived from sarcoma cells with potential immunostimulatory and antineoplastic activities. Upon...
• Autologous sarcoma lysate-pulsed dendritic cell vaccineA cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with lysates from sarcoma...
• Autologous SIRPa-depleted activated macrophages SI-101A preparation of autologous macrophages that are ex vivo activated and depleted of signal-regulatory protein...
• Autologous spermatogonial stem cellsA preparation of autologous spermatogonial stem cells (SSCs), that can potentially be used for...
• Autologous stem cell transplantA procedure in which a patient’s healthy stem cells (blood-forming cells) are collected from the blood or...
• Autologous TAAs-loaded autologous dendritic cells AV-GBM-1A preparation of autologous dendritic cells (DCs) loaded with immunogenic tumor-associated antigens (TAAs)...
• Autologous TBX-4000-treated peripheral blood mononuclear cells TBX-3400An autologous cell preparation in which the autologous peripheral blood mononuclear cells (PBMCs) are treated...
• Autologous TCR-engineered T cells IMA201A preparation of autologous T lymphocytes that are genetically modified with a lentiviral vector encoding a...
• Autologous TCR-engineered T cells IMA202A preparation of autologous T lymphocytes that are genetically modified with a lentiviral vector encoding a...
• Autologous TCRm-expressing T cells ET140203A preparation of autologous T lymphocytes that have been transduced with a lentiviral vector to express a...
• Autologous tetravalent dendritic cell vaccine MIDRIX4-LUNGA therapeutic cancer vaccine composed of autologous, dendritic cells (DCs) that have been loaded with a...
• Autologous TGFbeta-resistant HER2/EBV-specific cytotoxic T lymphocytesA preparation of transforming growth factor-beta (TGF-beta)-resistant Epstein-Barr virus (EBV)-specific...
• Autologous TGFbRII-knockout anti-interleukin-13 receptor alpha 2 CAR T cellsA preparation of autologous T lymphocytes engineered to express a chimeric antigen receptor (CAR) specific...
• Autologous TIM-4 chimeric engulfment receptor T cells CER-1236A preparation of autologous T cells genetically engineered to express a chimeric engulfment receptor (CER)...
• Autologous T-lymphocytes-expressing NY-ESO-1-C259-specific enhanced T-cell receptorsHuman autologous lymphocytes transduced with a retroviral vector encoding a T-cell receptor (TCR) specific...
• Autologous Tn-MUC1-specific CAR T lymphocytesA preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen...
• Autologous TNS9.3.55-transduced CD34-positive cellsA preparation of autologous, CD34-positive hematopoietic progenitor cells (HPCs) ex vivo transduced with...
• Autologous tolerogenic proinsulin peptide-loaded dendritic cells PIpepTolDCA vaccine composed of autologous tolerogenic dendritic cells (DCs) loaded with the beta cell protein...
• Autologous total tumor mRNA and CMV-pp65-flLAMP mRNA- loaded liposome vaccineAn mRNA-based, personalized cancer vaccine consisting of total tumor RNA (TTRNA) derived and amplified from...
• Autologous total tumor mRNA loaded liposome vaccineAn mRNA-based, personalized cancer vaccine consisting of total tumor RNA (TTRNA) derived from autologous...
• Autologous TP53 R175H mutant-specific HLA-A*02:01-restricted TCR gene engineered T lymphocytes NT-175A preparation of autologous T lymphocytes that have been genetically modified to express a T-cell receptor...
• Autologous TROP2-CAR-transduced PD-1-positive T cells T60cA preparation of autologous programmed cell death protein 1 (PD-1; PDCD1; CD279)-positive T lymphocytes...
• Autologous tumor cellA cancer cell from an individual's own tumor.
• Autologous tumor cell proteoliposome chronic lymphocytic leukemia vaccineAn autologous chronic lymphocytic leukemia cancer vaccine consisting of patient-specific membrane proteins...
• Autologous tumor cell vaccineA therapeutic agent produced by isolating tumor cells from an individual and processing these tumor cells...
• Autologous tumor cells/bacillus Calmette-Guérin/formalin-based vaccineA therapeutic personalized breast cancer vaccine composed of autologous tumor cells and bacillus...
• Autologous tumor infiltrating lymphocytes BST02A preparation of autologous tumor infiltrating lymphocytes (TILs) derived from the patient's resected tumor...
• Autologous tumor infiltrating lymphocytes C-TIL052AA preparation of autologous tumor infiltrating lymphocytes (TILs) derived from each patient's resected tumor...
• Autologous tumor infiltrating lymphocytes GT101A preparation of autologous tumor infiltrating lymphocytes (TILs) derived from each patient's resected tumor...
• Autologous tumor infiltrating lymphocytes GT201A preparation of autologous tumor infiltrating lymphocytes (TILs) derived from each patient's resected tumor...
• Autologous tumor infiltrating lymphocytes HV-101A preparation of autologous tumor infiltrating lymphocytes (TILs) derived from each patient's resected tumor...
• Autologous tumor infiltrating lymphocytes ITIL-168A preparation of autologous tumor infiltrating lymphocytes (TILs) derived from each patient's digested and...
• Autologous tumor infiltrating lymphocytes LM103A preparation of autologous tumor infiltrating lymphocytes (TILs) derived from each patient's resected tumor...
• Autologous tumor infiltrating lymphocytes LN-145A proprietary preparation of autologous tumor infiltrating lymphocytes (TILs), with potential...
• Autologous tumor infiltrating lymphocytes LN-145-S1A proprietary preparation of autologous tumor infiltrating lymphocytes (TILs), with potential...
• Autologous tumor infiltrating lymphocytes TBio-4101A preparation of autologous tumor infiltrating lymphocytes (TILs) derived from each patient's resected tumor...
• Autologous tumor killer cellsA preparation of autologous tumor killer cells (TKCs) which consists of the innate immune cells natural...
• Autologous tumor membrane vesicles vaccineAn autologous personalized tumor vaccine composed of tumor membrane vesicles (TMV) derived from the patient's...
• Autologous tumor-associated antigen-specific cytotoxic T lymphocytesA preparation of autologous cytotoxic T lymphocytes (CTLs) specifically reactive to the tumor associated...
• Autologous tumor-associated peptide antigen-pulsed dendritic cell vaccineA dendritic cell (DC)-based cancer vaccine composed of autologous DCs pulsed with specific tumor-associated...

3,095 of 17,717 terms in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.